Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The U.S. Food and Drug Administration (FDA) is seeking public input regarding the identification, assessment, and management of N-nitrosamine drug substance-related impurities (NDSRIs) during drug product development and regulatory evaluation. The deadline for submitting public comments is July 3, 2023.
MORE INFO ON www.natlawreview.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
